FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220738859> ?p ?o ?g. }

• W4220738859 endingPage "42" @default.
• W4220738859 startingPage "31" @default.
• W4220738859 abstract "Oncolytic viruses mediate antitumor responses through direct tumor cell lysis and induction of host antitumor immunity. However, the therapeutic efficacy of oncolytic viruses against malignant ascites has rarely been explored. This study aimed to evaluate the efficacy, safety, and immunomodulatory effect of an intraperitoneal injection of human type 5 recombinant adenovirus (called H101) against malignant ascites. Forty patients with malignant ascites were recruited and treated with intraperitoneal H101 in the Fudan University Shanghai Cancer Center. The 4-week clinical responses were determined by an objective assessment of ascites volume change. The ascites response rate and ascites control rate were 40% (16/40) and 75% (30/40), respectively. The major adverse events following intraperitoneal H101 administration were mild-to-moderate abdominal pain (8/40, 20.0%) and fever (11/40, 27.5%); no grade III/IV adverse events were observed. Mass cytometry and immunocytological analysis at baseline, and days 7 and 14 post-treatment showed that intraperitoneally injected H101 led to marked tumor cell depletion, increased dendritic cell and CD8+ T cell densities. H101-meditated tumor-specific immune activation on day 14 post-treatment was further identified by enzyme-linked immunospot assay. In conclusion, intraperitoneal H101 administration was well tolerated and effective in treating malignant ascites; thus, its immune activation ability may be a promising tool in combination with immunotherapy." @default.
• W4220738859 created "2022-04-03" @default.
• W4220738859 creator A5013094712 @default.
• W4220738859 creator A5013973657 @default.
• W4220738859 creator A5014183529 @default.
• W4220738859 creator A5042309447 @default.
• W4220738859 creator A5054352845 @default.
• W4220738859 creator A5062534675 @default.
• W4220738859 creator A5078988597 @default.
• W4220738859 creator A5084961529 @default.
• W4220738859 date "2022-06-01" @default.
• W4220738859 modified "2023-10-12" @default.
• W4220738859 title "Intraperitoneal oncolytic virotherapy for patients with malignant ascites: Characterization of clinical efficacy and antitumor immune response" @default.
• W4220738859 cites W106272877 @default.
• W4220738859 cites W1493283693 @default.
• W4220738859 cites W1514279614 @default.
• W4220738859 cites W1842568537 @default.
• W4220738859 cites W2012446836 @default.
• W4220738859 cites W2016080258 @default.
• W4220738859 cites W2018195451 @default.
• W4220738859 cites W2040327667 @default.
• W4220738859 cites W2045500028 @default.
• W4220738859 cites W2047157405 @default.
• W4220738859 cites W2051071528 @default.
• W4220738859 cites W2051639636 @default.
• W4220738859 cites W2064363496 @default.
• W4220738859 cites W2077895443 @default.
• W4220738859 cites W2094493963 @default.
• W4220738859 cites W2104958199 @default.
• W4220738859 cites W2105062803 @default.
• W4220738859 cites W2109274792 @default.
• W4220738859 cites W2117160925 @default.
• W4220738859 cites W2119990616 @default.
• W4220738859 cites W2121080406 @default.
• W4220738859 cites W2126564605 @default.
• W4220738859 cites W2134021845 @default.
• W4220738859 cites W2142573198 @default.
• W4220738859 cites W2153682404 @default.
• W4220738859 cites W2156694065 @default.
• W4220738859 cites W2167112387 @default.
• W4220738859 cites W2171164192 @default.
• W4220738859 cites W2198474977 @default.
• W4220738859 cites W2338890931 @default.
• W4220738859 cites W2475170675 @default.
• W4220738859 cites W2736591254 @default.
• W4220738859 cites W2750781282 @default.
• W4220738859 cites W2771259184 @default.
• W4220738859 cites W2792978998 @default.
• W4220738859 cites W2804481728 @default.
• W4220738859 cites W2896074158 @default.
• W4220738859 cites W2948841440 @default.
• W4220738859 cites W2970427296 @default.
• W4220738859 cites W2984628891 @default.
• W4220738859 cites W3011497962 @default.
• W4220738859 cites W3037716920 @default.
• W4220738859 cites W3047580238 @default.
• W4220738859 cites W3163716226 @default.
• W4220738859 doi "https://doi.org/10.1016/j.omto.2022.03.003" @default.
• W4220738859 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35399603" @default.
• W4220738859 hasPublicationYear "2022" @default.
• W4220738859 type Work @default.
• W4220738859 citedByCount "8" @default.
• W4220738859 countsByYear W42207388592022 @default.
• W4220738859 countsByYear W42207388592023 @default.
• W4220738859 crossrefType "journal-article" @default.
• W4220738859 hasAuthorship W4220738859A5013094712 @default.
• W4220738859 hasAuthorship W4220738859A5013973657 @default.
• W4220738859 hasAuthorship W4220738859A5014183529 @default.
• W4220738859 hasAuthorship W4220738859A5042309447 @default.
• W4220738859 hasAuthorship W4220738859A5054352845 @default.
• W4220738859 hasAuthorship W4220738859A5062534675 @default.
• W4220738859 hasAuthorship W4220738859A5078988597 @default.
• W4220738859 hasAuthorship W4220738859A5084961529 @default.
• W4220738859 hasBestOaLocation W42207388591 @default.
• W4220738859 hasConcept C126322002 @default.
• W4220738859 hasConcept C143998085 @default.
• W4220738859 hasConcept C167672396 @default.
• W4220738859 hasConcept C197934379 @default.
• W4220738859 hasConcept C203014093 @default.
• W4220738859 hasConcept C2780496750 @default.
• W4220738859 hasConcept C49744831 @default.
• W4220738859 hasConcept C71924100 @default.
• W4220738859 hasConcept C82210918 @default.
• W4220738859 hasConcept C8891405 @default.
• W4220738859 hasConcept C90924648 @default.
• W4220738859 hasConceptScore W4220738859C126322002 @default.
• W4220738859 hasConceptScore W4220738859C143998085 @default.
• W4220738859 hasConceptScore W4220738859C167672396 @default.
• W4220738859 hasConceptScore W4220738859C197934379 @default.
• W4220738859 hasConceptScore W4220738859C203014093 @default.
• W4220738859 hasConceptScore W4220738859C2780496750 @default.
• W4220738859 hasConceptScore W4220738859C49744831 @default.
• W4220738859 hasConceptScore W4220738859C71924100 @default.
• W4220738859 hasConceptScore W4220738859C82210918 @default.
• W4220738859 hasConceptScore W4220738859C8891405 @default.
• W4220738859 hasConceptScore W4220738859C90924648 @default.
• W4220738859 hasFunder F4320321001 @default.
• W4220738859 hasFunder F4320321881 @default.

• next